Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Liabilities (2016 - 2025)

AC Immune (ACIU) has disclosed Total Liabilities for 10 consecutive years, with $136.8 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 1.04% to $136.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $136.8 million through Dec 2025, up 1.04% year-over-year, with the annual reading at $136.8 million for FY2025, 1.04% up from the prior year.
  • Total Liabilities for Q4 2025 was $136.8 million at AC Immune, up from $135.4 million in the prior quarter.
  • The five-year high for Total Liabilities was $136.8 million in Q4 2025, with the low at $17.6 million in Q4 2022.
  • Average Total Liabilities over 5 years is $69.4 million, with a median of $32.0 million recorded in 2021.
  • The sharpest move saw Total Liabilities tumbled 44.95% in 2022, then soared 441.85% in 2024.
  • Over 5 years, Total Liabilities stood at $32.0 million in 2021, then tumbled by 44.95% to $17.6 million in 2022, then skyrocketed by 42.08% to $25.0 million in 2023, then skyrocketed by 441.85% to $135.4 million in 2024, then grew by 1.04% to $136.8 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $136.8 million, $135.4 million, and $25.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.